Arexvy is currently approved to prevent lower respiratory tract disease (LRTD) caused by RSV in individuals aged 60 years and older, and those 50 to 59 years of age who are at increased risk for LRTD ...

It’s as if sudden cardiac arrest is met with a resigned shrug: If it’s nearly impossible to predict and even harder to treat, ...

Endocrine Society experts estimate that between 5 and 14 percent of people with hypertension also have undiagnosed primary ...

Johnson & Johnson MedTech has announced the U.S. Food and Drug Administration (FDA) approval of an update to the VARIPULSE ...

Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of ...

In a new clinical practice guideline, the Endocrine Society advises universal screening of those with hypertension by ...

Q: I used to be a serious exerciser, but now that I am in my late 60s, I find it harder and harder to stay on track. Got any words ...